Glenmark Pharmaceuticals Ltd. records robust consolidated revenue of Rs. 29,096 Mn for Q3 FY 2023-24 ...Middle East

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical Company, today announced its financial results for the third quarter ended December 31, 2023.

Hence then, the article about glenmark pharmaceuticals ltd records robust consolidated revenue of rs 29 096 mn for q3 fy 2023 24 was published today ( Thursday 15/02/2024 - 08:20 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Glenmark Pharmaceuticals Ltd. records robust consolidated revenue of Rs. 29,096 Mn for Q3 FY 2023-24 )

Also on site :

• Cowardly Mamdani keeps bankrolling failure in NYC’s schools
• New York crime ‘revolves’ around recidivists — as state’s laws release danger onto our streets
• How Democrats’ rage over Virginia gerrymander exposes their larger contempt for democracy